SCHEMBL15575375

SCHEMBL15575375

CCOc1ccc(NC(=O)NCc2ccc(Oc3ccnc(C(=O)NC)c3)cc2)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.54
RAF1 P04049 9/20 0.54
EPHX2 P34913 3/20 0.54
KDR P35968 5/20 0.52
RET P07949 3/20 0.50
PLK4 O00444 2/20 0.50
AURKA O14965 2/20 0.50
MAPK13 O15264 2/20 0.50
MAP4K4 O95819 2/20 0.50
ABL1 P00519 2/20 0.50
LCK P06239 2/20 0.50
FYN P06241 2/20 0.50
LYN P07948 2/20 0.50
SRC P12931 2/20 0.50
RPS6KB1 P23443 2/20 0.50
EPHA2 P29317 2/20 0.50
AXL P30530 2/20 0.50
FRK P42685 2/20 0.50
MAPK9 P45984 2/20 0.50
BLK P51451 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15575227 0.92 MAPK14 (0.55) MAPK14RAF1EPHX2KDRRET
SCHEMBL15574712 0.86 RAF1 (0.64) MAPK14RAF1EPHX2KDRRET
SCHEMBL23747741 0.85 RAF1 (0.62) MAPK14RAF1EPHX2KDRRET
SCHEMBL13603485 0.84 KDR (0.55) MAPK14RAF1EPHX2KDRRET
SCHEMBL13603487 0.84 RAF1 (0.60) MAPK14RAF1EPHX2KDRRET
SCHEMBL13603809 0.84 KDR (0.61) MAPK14RAF1EPHX2KDRRET
SCHEMBL171253 0.84 KMT2A (0.61) MAPK14RAF1EPHX2KDRRET
SCHEMBL17000003 0.83 POLB (0.58) MAPK14RAF1EPHX2KDRRET
SCHEMBL15574494 0.82 RAF1 (0.64) MAPK14RAF1EPHX2KDRRET
SCHEMBL13611268 0.82 MAPK14 (0.59) MAPK14RAF1EPHX2KDRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2890380-A2 DDR2 INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS Merck Patent GmbH (DE) 2015-07-08 EP disclosed
WO-2014032755-A2 DDR2 INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS MERCK PATENT GMBH (DE) 2014-03-06 WO disclosed